(POAS) Phaos Technology Holdings - Overview
Sector: Healthcare | Industry: Medical Devices | Exchange: NYSE MKT (USA) | Market Cap: 36m USD | Total Return: -35.2% in 12m
Avg Turnover: 3.98M
Rev. Trend: -55.9%
Warnings
Negative Equity with losses - insolvent profile
Interest Coverage Ratio -606.0 is critical
Altman Z'' -15.00 < 1.0 - financial distress zone
Tailwinds
Idiosyncratic Leader
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary, specializes in the development and manufacturing of advanced optical microscopy solutions. The company’s product portfolio includes the Optonano system for high-resolution imaging and specialized hardware designed for industrial failure analysis, metrology, and biomedical research. These instruments utilize proprietary software to facilitate dimensional measurements and three-dimensional visualization for manufacturing and R&D sectors.
The microscopy market is increasingly driven by the miniaturization of semiconductors and advancements in life sciences, which require imaging capabilities beyond the diffraction limit of conventional light microscopes. As a micro-cap entity in the electronic instruments sub-industry, Phaos focuses on commercializing super-resolution technology to provide cost-effective alternatives to traditional electron microscopy. Investors may find it useful to examine ValueRay for deeper insights into the companys valuation metrics and competitive positioning.
Founded in 2017, the company targets a diverse client base ranging from industrial quality control labs to biomedical service providers. Its business model relies on the integration of hardware and specialized software to provide end-to-end imaging solutions for complex sample analysis.
- Adoption of Optonano technology in semiconductor failure analysis and inspection
- Revenue growth through expansion into global biomedical and R&D markets
- Scalability of high-margin proprietary microscopy software and digital solutions
- Increased demand for automated metrology tools in Singapore manufacturing sector
| Net Income: -5.14m TTM > 0 and > 6% of Revenue |
| FCF/TA: -2.01 > 0.02 and ΔFCF/TA -167.9 > 1.0 |
| NWC/Revenue: -1.36k% < 20% (prev 142.8%; Δ -1.50k% < -1%) |
| CFO/TA -1.89 > 3% & CFO -3.65m > Net Income -5.14m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.40 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (13.3m) vs prev 0.0% < -2% |
| Gross Margin: 22.10% > 18% (prev 0.48%; Δ 2.16k% > 0.5%) |
| Asset Turnover: 4.71% > 50% (prev 36.32%; Δ -31.60% > 0%) |
| Interest Coverage Ratio: -606.0 > 6 (EBITDA TTM -4.94m / Interest Expense TTM 8.46k) |
| A: -1.18 (Total Current Assets 1.52m - Total Current Liabilities 3.80m) / Total Assets 1.93m |
| B: -6.29 (Retained Earnings -12.2m / Total Assets 1.93m) |
| C: -1.44 (EBIT TTM -5.13m / Avg Total Assets 3.56m) |
| D: -3.12 (Book Value of Equity -12.2m / Total Liabilities 3.90m) |
| Altman-Z'' = -41.20 = D |
As of May 27, 2026, the stock is trading at USD 2.60 with a total of 1,893,405 shares traded.
Over the past week, the price has changed by +4.84%,
over one month by +32.65%,
over three months by +76.87% and
over the past year by -35.16%.
Phaos Technology Holdings has no consensus analysts rating.
Market Cap SGD = 45.3m (35.5m USD * 1.2766 USD.SGD)
P/S = 211.6893
Revenue TTM = 168k SGD
EBIT TTM = -5.13m SGD
EBITDA TTM = -4.94m SGD
Long Term Debt = 78.4k SGD (from longTermDebt, last fiscal year)
Short Term Debt = 165k SGD (from shortTermDebt, last quarter)
Debt = 398k SGD (from shortLongTermDebtTotal, last quarter) + Leases 132k
Net Debt = 268k SGD (calculated: Debt 398k - CCE 130k)
Enterprise Value = 45.6m SGD (45.3m + Debt 398k - CCE 130k)
Interest Coverage Ratio = -606.0 (Ebit TTM -5.13m / Interest Expense TTM 8.46k)
EV/FCF = -11.71x (Enterprise Value 45.6m / FCF TTM -3.89m)
FCF Yield = -8.54% (FCF TTM -3.89m / Enterprise Value 45.6m)
FCF Margin = -2.32k% (FCF TTM -3.89m / Revenue TTM 168k)
Net Margin = -3.06k% (Net Income TTM -5.14m / Revenue TTM 168k)
Gross Margin = 22.10% ((Revenue TTM 168k - Cost of Revenue TTM 131k) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 23.57 (Enterprise Value 45.6m / Total Assets 1.93m)
Interest Expense / Debt = 2.13% (Interest Expense 8.46k / Debt 398k)
Taxrate = 21.0% (US default 21%)
NOPAT = -4.05m (EBIT -5.13m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.40 (Total Current Assets 1.52m / Total Current Liabilities 3.80m)
Debt / Equity = -0.20 (negative equity) (Debt 398k / totalStockholderEquity, last quarter -1.96m)
Debt / EBITDA = -0.05 (negative EBITDA) (Net Debt 268k / EBITDA -4.94m)
Debt / FCF = -0.07 (negative FCF - burning cash) (Net Debt 268k / FCF TTM -3.89m)
Total Stockholder Equity = -1.96m (last fiscal year from totalStockholderEquity)
RoA = -144.3% (out of range, set to none)
RoE = -50.34% (Net Income TTM -5.14m / Total Stockholder Equity 10.2m)
RoCE = -49.88% (EBIT -5.13m / Capital Employed (Equity 10.2m + L.T.Debt 78.4k))
RoIC = 221.8% (negative operating profit) (NOPAT -4.05m / Invested Capital -1.83m)
WACC = -0.39% (negative - check inputs) (E(45.3m)/V(45.7m) * Re(-0.41%) + D(398k)/V(45.7m) * Rd(2.13%) * (1-Tc(0.21)))
Discount Rate = 5.29% (= Risk Free + ERP)
[DCF] Fair Price = unknown (Cash Flow -3.89m)
Revenue Correlation: -55.93 | Revenue CAGR: -49.24% | SUE: N/A | # QB: 0